Validation of a metabolite panel for early diagnosis of type 2 diabetes.

[1]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[2]  Nele Friedrich,et al.  Metabolomics in diabetes research. , 2012, The Journal of endocrinology.

[3]  D. Mozaffarian,et al.  Plasma phospholipid very-long-chain saturated fatty acids and incident diabetes in older adults: the Cardiovascular Health Study. , 2015, The American journal of clinical nutrition.

[4]  David Maxwell Chickering,et al.  Learning Bayesian Networks: The Combination of Knowledge and Statistical Data , 1994, Machine Learning.

[5]  H. Boeing,et al.  Adiponectin and protection against type 2 diabetes mellitus , 2003, The Lancet.

[6]  Hugo A. Katus,et al.  A New Metabolomic Signature in Type-2 Diabetes Mellitus and Its Pathophysiology , 2014, PloS one.

[7]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[8]  T. Lehtimäki,et al.  Circulating Metabolite Predictors of Glycemia in Middle-Aged Men and Women , 2012, Diabetes Care.

[9]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[10]  Suzette J. Bielinski,et al.  Use of diverse electronic medical record systems to identify genetic risk for type 2 diabetes within a genome-wide association study , 2012, J. Am. Medical Informatics Assoc..

[11]  M. S. Klein,et al.  Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application , 2015, Journal of diabetes research.

[12]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[13]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[14]  Wei Chen,et al.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. , 1995, The Journal of clinical investigation.

[15]  M. Westerterp-Plantenga,et al.  Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men. , 2000, The Journal of clinical endocrinology and metabolism.

[16]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[17]  H. Daniel,et al.  Glyoxylate, a New Marker Metabolite of Type 2 Diabetes , 2014, Journal of diabetes research.

[18]  Christian Gieger,et al.  Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting , 2010, PloS one.

[19]  Yoshua Bengio,et al.  Inference for the Generalization Error , 1999, Machine Learning.

[20]  K. Dungan.  1,5-anhydroglucitol (GlycoMark™) as a marker of short-term glycemic control and glycemic excursions , 2008, Expert review of molecular diagnostics.

[21]  P. Whincup,et al.  Associations of adiponectin with metabolic and vascular risk parameters in the British Regional Heart Study reveal stronger links to insulin resistance-related than to coronory heart disease risk-related parameters , 2007, International Journal of Obesity.

[22]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[23]  Ralph B D'Agostino,et al.  Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. , 2007, Archives of internal medicine.

[24]  Diederick E. Grobbee,et al.  The global burden of diabetes and its complications: an emerging pandemic , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[25]  D. Accili,et al.  Insulin Resistance in Humans Is Associated With Increased Plasma 12-Hydroxylated Bile Acids , 2013 .

[26]  Thomas J. Wang,et al.  Metabolite Traits and Genetic Risk Provide Complementary Information for the Prediction of Future Type 2 Diabetes , 2014, Diabetes Care.

[27]  E. Feskens,et al.  Comparison of fatty acid proportions in serum cholesteryl esters among people with different glucose tolerance status: the CoDAM study. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[28]  U. Smith,et al.  Interleukin-6 (IL-6) Induces Insulin Resistance in 3T3-L1 Adipocytes and Is, Like IL-8 and Tumor Necrosis Factor-α, Overexpressed in Human Fat Cells from Insulin-resistant Subjects* , 2003, Journal of Biological Chemistry.

[29]  P. Meikle,et al.  Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. , 2014, The American journal of clinical nutrition.

[30]  S. Cessie,et al.  Ridge Estimators in Logistic Regression , 1992 .

[31]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[32]  Gabi Kastenmüller,et al.  Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance , 2013, Diabetes.

[33]  J. Anderson,et al.  A comprehensive review of oral glucosamine use and effects on glucose metabolism in normal and diabetic individuals , 2010, Diabetes/metabolism research and reviews.

[34]  Christian Gieger,et al.  Biomarkers for Type 2 Diabetes and Impaired Fasting Glucose Using a Nontargeted Metabolomics Approach , 2013, Diabetes.

[35]  C. McCarty,et al.  Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank. , 2005, Personalized medicine.

[36]  Jaakko Tuomilehto,et al.  The diabetes risk score: a practical tool to predict type 2 diabetes risk. , 2003, Diabetes care.

[37]  Hitoshi Shimano,et al.  Physiological changes in circulating mannose levels in normal, glucose-intolerant, and diabetic subjects. , 2003, Metabolism: clinical and experimental.

[38]  A. Baron,et al.  Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics , 1987, Diabetes.

[39]  T. Funahashi,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .

[40]  Å. Lernmark,et al.  C‐peptide in the classification of diabetes in children and adolescents , 2012, Pediatric diabetes.

[41]  Albert Koulman,et al.  Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study , 2014, The lancet. Diabetes & endocrinology.